Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Inui

Showing results (51-60 of 567) with videos related to

Pageof 57
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1986
Mechanisms of gentamicin transport in kidney epithelial cell line (LLC-PK1)H Saito, K Inui, R Hori
Nihon Jinzo Gakkai Shi|October 1, 1996
Na(+)-dependent uptake of 1,5-anhydro-D-glucitol via the transport systems for D-glucose and D-mannose in the kidney epithelial cell line, LLC-PK1H Saito, T Ohtomo, K Inui
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 1, 1995
[Krabbe disease (globoid cell leukodystrophy)]N Sakai, K Inui, S Okada
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1992
Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: specific transport systems in apical and basolateral membranesK Inui, M Yamamoto, H Saito
Neuroscience|August 1, 1994
Baroreceptor inhibition of the locus coeruleus noradrenergic neuronsS Murase, K Inui, S Nosaka
Endoscopy|June 28, 2006
Bile duct cancers: what can EUS offer? Intraductal US, 3D-IDUS? FNA--is it possible?K Inui, H Miyoshi, J Yoshino
Biochemical Pharmacology|February 9, 1993
Expression of human intestinal dipeptide transporter in Xenopus laevis oocytesH Saito, T Ishii, K Inui
Journal of Pharmacobio-Dynamics|July 1, 1985
Differences in effects on drug absorption between dihydroxy and trihydroxy bile saltsT Kimura, K Inui, H Sezaki
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1983
Immunological evidence for deficiency in an activator protein for sulfatide sulfatase in a variant form of metachromatic leukodystrophyK Inui, M Emmett, D A Wenger
Clinical Genetics|January 1, 1985
Late onset GM2 gangliosidosis: an alpha-locus genetic compound with near normal hexosaminidase activityJ Charrow, K Inui, D A Wenger
Pageof 57

Showing results (51-60 of 567) with videos related to

Sort By:
Pageof 57
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1986
Mechanisms of gentamicin transport in kidney epithelial cell line (LLC-PK1)H Saito, K Inui, R Hori
Nihon Jinzo Gakkai Shi|October 1, 1996
Na(+)-dependent uptake of 1,5-anhydro-D-glucitol via the transport systems for D-glucose and D-mannose in the kidney epithelial cell line, LLC-PK1H Saito, T Ohtomo, K Inui
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 1, 1995
[Krabbe disease (globoid cell leukodystrophy)]N Sakai, K Inui, S Okada
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1992
Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: specific transport systems in apical and basolateral membranesK Inui, M Yamamoto, H Saito
Neuroscience|August 1, 1994
Baroreceptor inhibition of the locus coeruleus noradrenergic neuronsS Murase, K Inui, S Nosaka
Endoscopy|June 28, 2006
Bile duct cancers: what can EUS offer? Intraductal US, 3D-IDUS? FNA--is it possible?K Inui, H Miyoshi, J Yoshino
Biochemical Pharmacology|February 9, 1993
Expression of human intestinal dipeptide transporter in Xenopus laevis oocytesH Saito, T Ishii, K Inui
Journal of Pharmacobio-Dynamics|July 1, 1985
Differences in effects on drug absorption between dihydroxy and trihydroxy bile saltsT Kimura, K Inui, H Sezaki
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1983
Immunological evidence for deficiency in an activator protein for sulfatide sulfatase in a variant form of metachromatic leukodystrophyK Inui, M Emmett, D A Wenger
Clinical Genetics|January 1, 1985
Late onset GM2 gangliosidosis: an alpha-locus genetic compound with near normal hexosaminidase activityJ Charrow, K Inui, D A Wenger
Pageof 57